Calcium in PDB 8k5v: Crystal Structure of Human Prommp-9 Catalytic Domain in Complex with Inhibitor
Enzymatic activity of Crystal Structure of Human Prommp-9 Catalytic Domain in Complex with Inhibitor
All present enzymatic activity of Crystal Structure of Human Prommp-9 Catalytic Domain in Complex with Inhibitor:
3.4.24.35;
Protein crystallography data
The structure of Crystal Structure of Human Prommp-9 Catalytic Domain in Complex with Inhibitor, PDB code: 8k5v
was solved by
M.Kamitani,
M.Mima,
R.Nishikawa-Shimono,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
49.17 /
1.70
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
91.04,
73.82,
77.68,
90,
104.21,
90
|
R / Rfree (%)
|
17.8 /
21.7
|
Other elements in 8k5v:
The structure of Crystal Structure of Human Prommp-9 Catalytic Domain in Complex with Inhibitor also contains other interesting chemical elements:
Calcium Binding Sites:
The binding sites of Calcium atom in the Crystal Structure of Human Prommp-9 Catalytic Domain in Complex with Inhibitor
(pdb code 8k5v). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total 6 binding sites of Calcium where determined in the
Crystal Structure of Human Prommp-9 Catalytic Domain in Complex with Inhibitor, PDB code: 8k5v:
Jump to Calcium binding site number:
1;
2;
3;
4;
5;
6;
Calcium binding site 1 out
of 6 in 8k5v
Go back to
Calcium Binding Sites List in 8k5v
Calcium binding site 1 out
of 6 in the Crystal Structure of Human Prommp-9 Catalytic Domain in Complex with Inhibitor
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 1 of Crystal Structure of Human Prommp-9 Catalytic Domain in Complex with Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca303
b:31.6
occ:1.00
|
OE2
|
A:GLU208
|
2.1
|
34.9
|
1.0
|
OD2
|
A:ASP205
|
2.3
|
31.8
|
1.0
|
O
|
A:GLY183
|
2.3
|
38.5
|
1.0
|
OD1
|
A:ASP182
|
2.3
|
33.9
|
1.0
|
O
|
A:LEU187
|
2.3
|
35.4
|
1.0
|
O
|
A:ASP185
|
2.4
|
35.8
|
1.0
|
CD
|
A:GLU208
|
3.4
|
35.7
|
1.0
|
CG
|
A:ASP205
|
3.4
|
37.8
|
1.0
|
CG
|
A:ASP182
|
3.4
|
37.1
|
1.0
|
C
|
A:LEU187
|
3.5
|
32.4
|
1.0
|
C
|
A:GLY183
|
3.6
|
39.3
|
1.0
|
C
|
A:ASP185
|
3.6
|
35.7
|
1.0
|
N
|
A:ASP185
|
3.9
|
38.1
|
1.0
|
OD2
|
A:ASP182
|
3.9
|
37.3
|
1.0
|
N
|
A:LEU187
|
4.0
|
33.7
|
1.0
|
C
|
A:LYS184
|
4.1
|
40.2
|
1.0
|
N
|
A:GLY183
|
4.1
|
37.5
|
1.0
|
CB
|
A:ASP205
|
4.1
|
35.3
|
1.0
|
CG
|
A:GLU208
|
4.3
|
35.6
|
1.0
|
CA
|
A:ASP185
|
4.3
|
36.9
|
1.0
|
OE1
|
A:GLU208
|
4.3
|
37.7
|
1.0
|
OD1
|
A:ASP205
|
4.3
|
35.7
|
1.0
|
CA
|
A:LEU187
|
4.4
|
33.1
|
1.0
|
N
|
A:ASP182
|
4.4
|
33.4
|
1.0
|
C
|
A:ASP182
|
4.4
|
38.7
|
1.0
|
N
|
A:LYS184
|
4.4
|
36.0
|
1.0
|
CA
|
A:LYS184
|
4.4
|
38.2
|
1.0
|
C
|
A:GLY186
|
4.4
|
35.3
|
1.0
|
O
|
A:LYS184
|
4.5
|
37.5
|
1.0
|
CA
|
A:GLY183
|
4.5
|
38.1
|
1.0
|
N
|
A:LEU188
|
4.5
|
30.3
|
1.0
|
CD1
|
A:LEU187
|
4.6
|
47.0
|
1.0
|
N
|
A:GLY186
|
4.6
|
37.7
|
1.0
|
CB
|
A:ASP182
|
4.7
|
39.8
|
1.0
|
CA
|
A:LEU188
|
4.7
|
30.0
|
1.0
|
CA
|
A:ASP182
|
4.7
|
39.6
|
1.0
|
CG
|
A:LEU187
|
4.8
|
44.7
|
1.0
|
CA
|
A:GLY186
|
4.8
|
37.6
|
1.0
|
O
|
A:ASP182
|
4.9
|
39.7
|
1.0
|
|
Calcium binding site 2 out
of 6 in 8k5v
Go back to
Calcium Binding Sites List in 8k5v
Calcium binding site 2 out
of 6 in the Crystal Structure of Human Prommp-9 Catalytic Domain in Complex with Inhibitor
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 2 of Crystal Structure of Human Prommp-9 Catalytic Domain in Complex with Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca304
b:46.0
occ:1.00
|
OD2
|
A:ASP131
|
2.3
|
38.6
|
1.0
|
O
|
A:ASP206
|
2.4
|
38.7
|
1.0
|
O
|
A:GLU208
|
2.4
|
34.6
|
1.0
|
OD1
|
A:ASP206
|
2.5
|
33.8
|
1.0
|
O
|
A:HOH402
|
2.6
|
40.9
|
1.0
|
CG
|
A:ASP131
|
3.2
|
46.0
|
1.0
|
C
|
A:ASP206
|
3.3
|
35.6
|
1.0
|
CG
|
A:ASP206
|
3.3
|
35.1
|
1.0
|
OD1
|
A:ASP131
|
3.4
|
47.0
|
1.0
|
C
|
A:GLU208
|
3.6
|
32.2
|
1.0
|
CA
|
A:ASP206
|
3.7
|
33.9
|
1.0
|
CB
|
A:ASP206
|
4.0
|
35.3
|
1.0
|
OG
|
A:SER129
|
4.1
|
35.6
|
1.0
|
OD2
|
A:ASP206
|
4.2
|
39.0
|
1.0
|
N
|
A:GLU208
|
4.2
|
32.7
|
1.0
|
CD1
|
A:TRP210
|
4.3
|
30.0
|
1.0
|
CA
|
A:LEU209
|
4.3
|
35.2
|
1.0
|
N
|
A:LEU209
|
4.3
|
33.5
|
1.0
|
N
|
A:ASP207
|
4.4
|
34.0
|
1.0
|
C
|
A:ASP207
|
4.4
|
36.6
|
1.0
|
O
|
A:HOH476
|
4.5
|
59.2
|
1.0
|
O
|
A:HOH441
|
4.5
|
35.1
|
1.0
|
CA
|
A:GLU208
|
4.6
|
31.4
|
1.0
|
CB
|
A:ASP131
|
4.6
|
41.3
|
1.0
|
CA
|
A:ASP207
|
4.7
|
36.8
|
1.0
|
N
|
A:TRP210
|
4.7
|
33.6
|
1.0
|
NE1
|
A:TRP210
|
4.9
|
32.9
|
1.0
|
O
|
A:ASP207
|
5.0
|
37.7
|
1.0
|
|
Calcium binding site 3 out
of 6 in 8k5v
Go back to
Calcium Binding Sites List in 8k5v
Calcium binding site 3 out
of 6 in the Crystal Structure of Human Prommp-9 Catalytic Domain in Complex with Inhibitor
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 3 of Crystal Structure of Human Prommp-9 Catalytic Domain in Complex with Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca305
b:33.9
occ:1.00
|
O
|
A:GLY197
|
2.3
|
32.7
|
1.0
|
O
|
A:ASP165
|
2.3
|
30.3
|
1.0
|
O
|
A:HOH404
|
2.4
|
32.1
|
1.0
|
O
|
A:HOH438
|
2.4
|
33.5
|
1.0
|
OD1
|
A:ASP201
|
2.4
|
34.4
|
1.0
|
O
|
A:GLN199
|
2.5
|
32.0
|
1.0
|
C
|
A:ASP165
|
3.4
|
31.4
|
1.0
|
CG
|
A:ASP201
|
3.4
|
38.6
|
1.0
|
C
|
A:GLY197
|
3.5
|
37.7
|
1.0
|
C
|
A:GLN199
|
3.7
|
34.9
|
1.0
|
OD2
|
A:ASP201
|
3.9
|
34.0
|
1.0
|
N
|
A:ASP201
|
4.2
|
27.8
|
1.0
|
C
|
A:ILE198
|
4.2
|
35.1
|
1.0
|
O
|
A:ALA164
|
4.2
|
39.8
|
1.0
|
CA
|
A:ASP165
|
4.3
|
32.4
|
1.0
|
N
|
A:GLN199
|
4.3
|
35.3
|
1.0
|
O
|
A:ILE198
|
4.3
|
32.4
|
1.0
|
C
|
A:GLY200
|
4.3
|
26.7
|
1.0
|
N
|
A:ILE166
|
4.4
|
32.3
|
1.0
|
CA
|
A:GLY197
|
4.4
|
42.6
|
1.0
|
CA
|
A:GLY200
|
4.4
|
27.6
|
1.0
|
N
|
A:GLY197
|
4.4
|
42.6
|
1.0
|
O
|
A:HOH409
|
4.4
|
43.9
|
1.0
|
O
|
A:GLY195
|
4.5
|
34.4
|
1.0
|
N
|
A:GLY200
|
4.5
|
30.2
|
1.0
|
N
|
A:ILE198
|
4.5
|
36.4
|
1.0
|
CA
|
A:ILE198
|
4.6
|
38.0
|
1.0
|
N
|
A:VAL167
|
4.6
|
30.7
|
1.0
|
CA
|
A:GLN199
|
4.6
|
33.3
|
1.0
|
CB
|
A:ASP201
|
4.6
|
34.4
|
1.0
|
CA
|
A:ILE166
|
4.7
|
33.0
|
1.0
|
CA
|
A:ASP201
|
4.7
|
30.8
|
1.0
|
C
|
A:PRO196
|
4.8
|
43.3
|
1.0
|
O
|
A:HOH413
|
4.8
|
38.8
|
1.0
|
CG2
|
A:VAL167
|
4.9
|
35.1
|
1.0
|
CH2
|
A:TRP116
|
4.9
|
30.9
|
1.0
|
O
|
A:PRO196
|
5.0
|
40.4
|
1.0
|
|
Calcium binding site 4 out
of 6 in 8k5v
Go back to
Calcium Binding Sites List in 8k5v
Calcium binding site 4 out
of 6 in the Crystal Structure of Human Prommp-9 Catalytic Domain in Complex with Inhibitor
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 4 of Crystal Structure of Human Prommp-9 Catalytic Domain in Complex with Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca303
b:30.3
occ:1.00
|
OE2
|
B:GLU208
|
2.2
|
39.8
|
1.0
|
O
|
B:GLY183
|
2.3
|
33.0
|
1.0
|
O
|
B:ASP185
|
2.3
|
34.3
|
1.0
|
OD2
|
B:ASP205
|
2.3
|
31.3
|
1.0
|
O
|
B:LEU187
|
2.3
|
31.2
|
1.0
|
OD1
|
B:ASP182
|
2.4
|
33.6
|
1.0
|
CG
|
B:ASP205
|
3.4
|
31.2
|
1.0
|
CD
|
B:GLU208
|
3.5
|
39.2
|
1.0
|
C
|
B:ASP185
|
3.5
|
33.8
|
1.0
|
C
|
B:LEU187
|
3.5
|
30.9
|
1.0
|
CG
|
B:ASP182
|
3.5
|
34.9
|
1.0
|
C
|
B:GLY183
|
3.5
|
37.0
|
1.0
|
N
|
B:LEU187
|
3.8
|
31.3
|
1.0
|
N
|
B:ASP185
|
3.9
|
34.9
|
1.0
|
OD2
|
B:ASP182
|
4.0
|
33.2
|
1.0
|
C
|
B:LYS184
|
4.1
|
37.5
|
1.0
|
N
|
B:GLY183
|
4.1
|
33.0
|
1.0
|
CA
|
B:LEU187
|
4.2
|
35.2
|
1.0
|
CB
|
B:ASP205
|
4.2
|
26.2
|
1.0
|
CA
|
B:ASP185
|
4.2
|
33.7
|
1.0
|
OE1
|
B:GLU208
|
4.3
|
37.5
|
1.0
|
CG
|
B:GLU208
|
4.3
|
33.1
|
1.0
|
C
|
B:GLY186
|
4.3
|
34.0
|
1.0
|
OD1
|
B:ASP205
|
4.3
|
32.5
|
1.0
|
C
|
B:ASP182
|
4.4
|
33.9
|
1.0
|
N
|
B:ASP182
|
4.4
|
34.6
|
1.0
|
CB
|
B:LEU187
|
4.4
|
41.3
|
1.0
|
CA
|
B:GLY183
|
4.4
|
34.8
|
1.0
|
N
|
B:LYS184
|
4.5
|
35.1
|
1.0
|
N
|
B:GLY186
|
4.5
|
30.4
|
1.0
|
O
|
B:LYS184
|
4.5
|
36.0
|
1.0
|
N
|
B:LEU188
|
4.5
|
28.6
|
1.0
|
CA
|
B:LYS184
|
4.6
|
39.9
|
1.0
|
CB
|
B:ASP182
|
4.7
|
33.8
|
1.0
|
CA
|
B:GLY186
|
4.7
|
33.3
|
1.0
|
CA
|
B:LEU188
|
4.7
|
25.2
|
1.0
|
CA
|
B:ASP182
|
4.7
|
34.1
|
1.0
|
O
|
B:ASP182
|
4.8
|
38.0
|
1.0
|
O
|
B:GLY186
|
5.0
|
32.5
|
1.0
|
|
Calcium binding site 5 out
of 6 in 8k5v
Go back to
Calcium Binding Sites List in 8k5v
Calcium binding site 5 out
of 6 in the Crystal Structure of Human Prommp-9 Catalytic Domain in Complex with Inhibitor
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 5 of Crystal Structure of Human Prommp-9 Catalytic Domain in Complex with Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca304
b:43.2
occ:1.00
|
O
|
B:HOH477
|
2.2
|
50.1
|
1.0
|
O
|
B:GLU208
|
2.3
|
32.3
|
1.0
|
O
|
B:ASP206
|
2.4
|
31.7
|
1.0
|
OD2
|
B:ASP131
|
2.4
|
34.5
|
1.0
|
O
|
B:HOH443
|
2.5
|
54.7
|
1.0
|
OD1
|
B:ASP206
|
2.5
|
32.1
|
1.0
|
CG
|
B:ASP131
|
3.2
|
39.4
|
1.0
|
OD1
|
B:ASP131
|
3.2
|
44.3
|
1.0
|
C
|
B:ASP206
|
3.4
|
27.6
|
1.0
|
CG
|
B:ASP206
|
3.4
|
31.5
|
1.0
|
C
|
B:GLU208
|
3.5
|
33.3
|
1.0
|
CA
|
B:ASP206
|
3.8
|
29.6
|
1.0
|
OG
|
B:SER129
|
4.0
|
29.7
|
1.0
|
CB
|
B:ASP206
|
4.1
|
30.4
|
1.0
|
OD2
|
B:ASP206
|
4.3
|
37.0
|
1.0
|
N
|
B:LEU209
|
4.3
|
32.1
|
1.0
|
N
|
B:GLU208
|
4.3
|
30.6
|
1.0
|
CA
|
B:LEU209
|
4.4
|
35.2
|
1.0
|
N
|
B:ASP207
|
4.4
|
27.6
|
1.0
|
CD1
|
B:TRP210
|
4.4
|
29.1
|
1.0
|
C
|
B:ASP207
|
4.5
|
35.9
|
1.0
|
CA
|
B:GLU208
|
4.6
|
31.6
|
1.0
|
O
|
B:HOH413
|
4.6
|
40.6
|
1.0
|
CB
|
B:ASP131
|
4.6
|
34.1
|
1.0
|
CA
|
B:ASP207
|
4.7
|
32.5
|
1.0
|
N
|
B:TRP210
|
4.7
|
31.4
|
1.0
|
NE1
|
B:TRP210
|
5.0
|
29.6
|
1.0
|
O
|
B:ASP207
|
5.0
|
35.6
|
1.0
|
|
Calcium binding site 6 out
of 6 in 8k5v
Go back to
Calcium Binding Sites List in 8k5v
Calcium binding site 6 out
of 6 in the Crystal Structure of Human Prommp-9 Catalytic Domain in Complex with Inhibitor
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 6 of Crystal Structure of Human Prommp-9 Catalytic Domain in Complex with Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca305
b:31.9
occ:1.00
|
O
|
B:GLN199
|
2.3
|
29.6
|
1.0
|
O
|
B:GLY197
|
2.3
|
30.8
|
1.0
|
O
|
B:ASP165
|
2.4
|
27.6
|
1.0
|
OD1
|
B:ASP201
|
2.4
|
27.9
|
1.0
|
O
|
B:HOH427
|
2.4
|
30.4
|
1.0
|
O
|
B:HOH404
|
2.4
|
27.9
|
1.0
|
CG
|
B:ASP201
|
3.4
|
30.5
|
1.0
|
C
|
B:GLN199
|
3.5
|
27.8
|
1.0
|
C
|
B:ASP165
|
3.6
|
27.6
|
1.0
|
C
|
B:GLY197
|
3.6
|
37.2
|
1.0
|
OD2
|
B:ASP201
|
3.9
|
29.4
|
1.0
|
C
|
B:ILE198
|
4.1
|
32.5
|
1.0
|
N
|
B:GLN199
|
4.2
|
28.3
|
1.0
|
N
|
B:ASP201
|
4.2
|
26.3
|
1.0
|
O
|
B:GLY195
|
4.3
|
35.9
|
1.0
|
O
|
B:ILE198
|
4.3
|
32.1
|
1.0
|
N
|
B:GLY197
|
4.4
|
35.8
|
1.0
|
N
|
B:GLY200
|
4.4
|
28.9
|
1.0
|
C
|
B:GLY200
|
4.4
|
28.1
|
1.0
|
CA
|
B:GLY200
|
4.4
|
29.4
|
1.0
|
O
|
B:ALA164
|
4.4
|
32.4
|
1.0
|
CA
|
B:ASP165
|
4.4
|
29.0
|
1.0
|
O
|
B:HOH426
|
4.4
|
34.4
|
1.0
|
CA
|
B:GLY197
|
4.4
|
36.8
|
1.0
|
CA
|
B:GLN199
|
4.5
|
28.5
|
1.0
|
N
|
B:ILE198
|
4.5
|
36.6
|
1.0
|
O
|
B:HOH507
|
4.5
|
37.7
|
1.0
|
N
|
B:ILE166
|
4.5
|
28.2
|
1.0
|
CA
|
B:ILE198
|
4.6
|
31.8
|
1.0
|
N
|
B:VAL167
|
4.6
|
25.0
|
1.0
|
CB
|
B:ASP201
|
4.6
|
27.6
|
1.0
|
CA
|
B:ILE166
|
4.7
|
26.7
|
1.0
|
C
|
B:PRO196
|
4.7
|
36.4
|
1.0
|
CA
|
B:ASP201
|
4.8
|
27.3
|
1.0
|
O
|
B:HOH455
|
4.9
|
33.9
|
1.0
|
CG2
|
B:VAL167
|
5.0
|
27.7
|
1.0
|
|
Reference:
R.Nishikawa-Shimono,
M.Kuwabara,
S.Fujisaki,
D.Matsuda,
M.Endo,
M.Kamitani,
A.Futamura,
Y.Nomura,
T.Yamaguchi-Sasaki,
T.Yabuuchi,
C.Yamaguchi,
N.Tanaka-Yamamoto,
S.Satake,
K.Abe-Sato,
K.Funayama,
M.Sakata,
S.Takahashi,
K.Hirano,
T.Fukunaga,
Y.Uozumi,
S.Kato,
Y.Tamura,
T.Nakamori,
M.Mima,
C.Mishima-Tsumagari,
D.Nozawa,
Y.Imai,
T.Asami.
Discovery of Novel Indole Derivatives As Potent and Selective Inhibitors of Prommp-9 Activation. Bioorg.Med.Chem.Lett. V. 97 29541 2023.
ISSN: ESSN 1464-3405
PubMed: 37952596
DOI: 10.1016/J.BMCL.2023.129541
Page generated: Fri Jul 19 10:51:03 2024
|